Renaissance Technologies LLC Sells 59,500 Shares of Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT)

Renaissance Technologies LLC trimmed its holdings in shares of Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) by 7.8% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 703,810 shares of the medical device company’s stock after selling 59,500 shares during the quarter. Renaissance Technologies LLC owned 0.54% of Xtant Medical worth $443,000 as of its most recent filing with the SEC.

Separately, Vanguard Group Inc. raised its stake in shares of Xtant Medical by 3.2% in the 1st quarter. Vanguard Group Inc. now owns 1,548,312 shares of the medical device company’s stock valued at $1,812,000 after purchasing an additional 48,319 shares during the period. Institutional investors and hedge funds own 69.33% of the company’s stock.

Xtant Medical Stock Down 1.2 %

XTNT stock opened at $0.59 on Friday. The company has a quick ratio of 1.01, a current ratio of 2.44 and a debt-to-equity ratio of 0.49. The stock has a market cap of $77.30 million, a PE ratio of -59.32 and a beta of 0.36. Xtant Medical Holdings, Inc. has a fifty-two week low of $0.51 and a fifty-two week high of $1.45.

Xtant Medical (NYSEAMERICAN:XTNT) last released its quarterly earnings results on Thursday, August 8th. The medical device company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.01). The firm had revenue of $29.94 million for the quarter. Xtant Medical had a negative return on equity of 6.71% and a negative net margin of 3.00%.

Xtant Medical Profile

Xtant Medical Holdings, Inc provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier.